The United States Immuno-Oncology Drugs Market is expanding as researchers investigate new ways to use the immune system to recognize and attack cancer cells. Pharmaceutical and biotechnology companies are developing therapies that target immune checkpoints, modify immune signaling, and use engineered immune cells to fight selected cancers. Increasing clinical research, advancements in...